ContextVision AB logo

ContextVision AB (0L8Z)

Market Closed
1 Dec, 15:30
LSE LSE
kr
4. 25
+0.01
+0.24%
kr
8.79B Market Cap
16.04 P/E Ratio
5.97% Div Yield
3,660 Volume
0.5 Eps
kr 4.24
Previous Close
Day Range
4.25 4.25
Year Range
4.25 9.48
Want to track 0L8Z and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 74 days

Summary

0L8Z closed Monday higher at kr4.25, an increase of 0.24% from Friday's close, completing a monthly increase of 0% or kr0. Over the past 12 months, 0L8Z stock lost -23.84%.
0L8Z is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 19, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on LSE (NOK).

0L8Z Chart

Similar

UU
United Utilities Group PLC
1,208 GBX
-1.19%
Investment AB Öresund
kr 112.4
-2.43%
Halyk Savings Bank of Kazakhstan JSC
$ 20.25
0%
JPMorgan Global Growth & Income Fund
570 GBX
+0.35%
Aegon N.V. 6.125% SNR NTS 15/12/2031 GBP1000 '6'
£ -
-

ContextVision AB (0L8Z) FAQ

What is the stock price today?

The current price is kr4.25.

On which exchange is it traded?

ContextVision AB is listed on LSE.

What is its stock symbol?

The ticker symbol is 0L8Z.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 5.97%.

What is its market cap?

As of today, the market cap is 8.79B.

When is the next earnings date?

The next earnings report will release on Feb 19, 2026.

Has ContextVision AB ever had a stock split?

No, there has never been a stock split.

ContextVision AB Profile

Insurance Industry
Financials Sector
Dr. Gerald Potzsch CEO
LSE Exchange
- ISIN
Sweden Country
44 Employees
- Last Dividend
19 Aug 2020 Last Split
- IPO Date

Overview

ContextVision AB (publ) is a pioneering medical technology software company that specializes in the field of image analysis and enhancement for medical imaging systems. With a broad operational base spread across Asia, Europe, and the United States, the company leverages its expertise to deliver superior quality imaging solutions across various medical modalities. Founded in 1983, ContextVision has established itself as a key player in the industry, offering state-of-the-art software solutions from its headquarters in Stockholm, Sweden. The company primarily focuses on developing advanced imaging software that caters to 2D, 3D, and 4D ultrasound, radiography, magnetic resonance imaging (MRI), as well as veterinary applications, thus supporting professionals in delivering accurate diagnoses and treatments.

Products and Services

  • Rivent

    Rivent leads ContextVision's lineup with its exceptional image quality enhancement capabilities tailored for various ultrasound systems. It is designed to serve a broad spectrum of applications including women's health, general imaging, cardiovascular, and point of care. The innovation behind Rivent ensures that ultrasound practitioners across different fields can rely on it for clearer, more detailed images, thereby facilitating improved patient outcomes.

  • Rivent Mobile

    Extending the capabilities of traditional ultrasound systems into the realm of mobility, Rivent Mobile targets the burgeoning market of handheld ultrasound devices. This product adapts ContextVision's advanced imaging software for use on mobile phones and tablets, providing healthcare professionals with on-the-go access to high-quality ultrasound imaging. It represents a significant advancement in making diagnostic imaging more accessible and convenient, particularly in remote or resource-limited settings.

  • Rivent 3D

    Building on the robust foundation of its Rivent technology, Rivent 3D introduces specialized image enhancement solutions tailored for 3D ultrasound applications. This product underscores ContextVision's commitment to pushing the boundaries of ultrasound imaging, offering clinicians three-dimensional imaging with unprecedented clarity and depth, thus making it easier to diagnose and monitor complex conditions.

  • Altumira/Altumira Plus

    Altumira represents ContextVision's venture into the field of digital radiography, offering a versatile platform that brings together the latest advancements in image processing technology. With Altumira and its enhanced version, Altumira Plus, users are empowered with superior image clarity and detail, ensuring a higher level of diagnostic confidence in radiographic examinations.

  • Orthopedic Package

    Addressing the specific needs of orthopedic imaging, ContextVision has developed the Orthopedic Package. This tailored solution incorporates advanced image processing technologies to deliver enhanced image quality, specifically optimized for the challenging requirements of orthopedic applications. It marks a significant step forward in supporting orthopedic specialists with detailed, high-resolution images crucial for both diagnosis and treatment planning.

  • GOPView MRI2Plus

    GOPView MRI2Plus rounds out ContextVision's comprehensive portfolio with a powerful image enhancement solution for MRI. By significantly improving the clarity and contrast of MRI scans, GOPView MRI2Plus enables radiologists to conduct more precise evaluations. This technology plays a critical role in enhancing the diagnostic process, offering a clearer view of anatomical structures and potential abnormalities.

Contact Information

Address: Gamla Brogatan 26
Phone: 46 87 50 35 50